The P2X7 receptor/NLRP3 inflammasome signaling axis in sepsis: molecular mechanisms, organ-specific pathophysiology, and emerging therapeutic strategies

Review ArticleAçık Erişim

Özet

Sepsis remains a leading cause of mortality in intensive care units worldwide, representing life-threatening organ dysfunction arising from dysregulated host responses to infection. The purinergic P2X7 receptor (P2X7R) and the NOD-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasome have emerged as critical regulators of inflammatory responses during sepsis pathogenesis. Extracellular adenosine triphosphate (ATP), released as a danger-associated molecular pattern from damaged and dying cells, activates the P2X7R, triggering potassium efflux that serves as the cardinal signal for NLRP3 inflammasome assembly. The activated inflammasome complex mediates caspase-1-dependent proteolytic maturation of the proinflammatory cytokines interleukin-1β (IL-1β) and IL-18, while simultaneously inducing gasdermin D (GSDMD)-mediated pyroptotic cell death—an inflammatory form of programmed cell death characterized by membrane pore formation, cellular swelling, and release of intracellular contents. Paradoxically, emerging evidence indicates that excessive P2X7R activation during sepsis progression induces profound mitochondrial dysfunction in circulating monocytes, leading to impaired NLRP3 inflammasome function and a state of immunoparalysis that coincides with an increased mortality. This comprehensive review examines the molecular mechanisms governing P2X7/NLRP3 signaling in sepsis; critically evaluates its dual and seemingly contradictory roles in hyperinflammation versus immunosuppression; delineates organ-specific manifestations across the lung, kidney, heart, brain, liver, and intestine; and systematically evaluates emerging therapeutic strategies including direct NLRP3 inhibitors such as MCC950, selective P2X7R antagonists, IL-1 receptor blockade, GSDMD inhibitors, and natural compounds with inflammasome-modulating properties. Understanding the temporal dynamics of this signaling axis is crucial for developing precision-targeted interventions that appropriately balance pathogen clearance with prevention of excessive inflammatory tissue damage. © The Author(s), under exclusive licence to Springer Nature B.V. 2026.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/10401Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1007/s11302-026-10140-yYayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorÜstündağ, Hilal
dc.date.accessioned2026-10-18T20:25:37.417446319Z
dc.date.available2026-10-18T20:25:37.417446319Z
dc.date.issued2026
dc.description.abstractSepsis remains a leading cause of mortality in intensive care units worldwide, representing life-threatening organ dysfunction arising from dysregulated host responses to infection. The purinergic P2X7 receptor (P2X7R) and the NOD-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasome have emerged as critical regulators of inflammatory responses during sepsis pathogenesis. Extracellular adenosine triphosphate (ATP), released as a danger-associated molecular pattern from damaged and dying cells, activates the P2X7R, triggering potassium efflux that serves as the cardinal signal for NLRP3 inflammasome assembly. The activated inflammasome complex mediates caspase-1-dependent proteolytic maturation of the proinflammatory cytokines interleukin-1β (IL-1β) and IL-18, while simultaneously inducing gasdermin D (GSDMD)-mediated pyroptotic cell death—an inflammatory form of programmed cell death characterized by membrane pore formation, cellular swelling, and release of intracellular contents. Paradoxically, emerging evidence indicates that excessive P2X7R activation during sepsis progression induces profound mitochondrial dysfunction in circulating monocytes, leading to impaired NLRP3 inflammasome function and a state of immunoparalysis that coincides with an increased mortality. This comprehensive review examines the molecular mechanisms governing P2X7/NLRP3 signaling in sepsis; critically evaluates its dual and seemingly contradictory roles in hyperinflammation versus immunosuppression; delineates organ-specific manifestations across the lung, kidney, heart, brain, liver, and intestine; and systematically evaluates emerging therapeutic strategies including direct NLRP3 inhibitors such as MCC950, selective P2X7R antagonists, IL-1 receptor blockade, GSDMD inhibitors, and natural compounds with inflammasome-modulating properties. Understanding the temporal dynamics of this signaling axis is crucial for developing precision-targeted interventions that appropriately balance pathogen clearance with prevention of excessive inflammatory tissue damage. © The Author(s), under exclusive licence to Springer Nature B.V. 2026.
dc.identifier.doi10.1007/s11302-026-10140-y
dc.identifier.eissn1573-9546
dc.identifier.issn1573-9538
dc.identifier.issue2
dc.identifier.pmcidPMC12972434
dc.identifier.pmid41803506
dc.identifier.scopus2-s2.0-105032839465
dc.identifier.startpage26
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/10401
dc.identifier.volume22
dc.identifier.wosWOS:001711475800001
dc.language.isoen
dc.publisherSpringer Science and Business Media B.V.
dc.relation.ispartofPurinergic Signalling
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCytokine storm
dc.subjectGasdermin D
dc.subjectImmunoparalysis
dc.subjectMCC950
dc.subjectMultiple organ dysfunction syndrome
dc.subjectNLRP3 inflammasome
dc.subjectP2X7 receptor
dc.subjectPurinergic signaling
dc.subjectPyroptosis
dc.subjectSepsis
dc.subjectAnimals
dc.subjectHumans
dc.subjectInflammasomes
dc.subjectNLR Family, Pyrin Domain-Containing 3 Protein
dc.subjectReceptors, Purinergic P2X7
dc.subjectSignal Transduction
dc.subjectadenosine triphosphate
dc.subjectcytokine
dc.subjectgasdermin
dc.subjectiboctadekin
dc.subjectinflammasome
dc.subjectinterleukin 1
dc.subjectinterleukin 18
dc.subjectinterleukin 1beta
dc.subjectinterleukin 1beta converting enzyme
dc.subjectnucleotide binding oligomerization domain like receptor
dc.subjectpurinergic P2X7 receptor
dc.subjectcryopyrin
dc.subjectanimal cell
dc.subjectapoptosis
dc.titleThe P2X7 receptor/NLRP3 inflammasome signaling axis in sepsis: molecular mechanisms, organ-specific pathophysiology, and emerging therapeutic strategies
dc.typeReview Article
dspace.entity.typePublication
rdl.citation.scopus11
rdl.citation.wos12
rdl.departmentDepartment of Physiology, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan, Türkiye. hilal.ustundag@erzincan.edu.tr.
rdl.oa.statusgreen
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)